01 1Laurus Labs
01 1BICTEGRAVIR SODIUM
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2022-01-26
Pay. Date : 2021-11-24
DMF Number : 36444
Submission : 2021-12-24
Status : Active
Type : II
20
Laurus Labs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is BICTEGRAVIR SODIUM, with a corresponding US DMF Number 36444.
Remarkably, this DMF maintains an Active status since its submission on December 24, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 26, 2022, and payment made on November 24, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II
